The Helicobacter pylori Antigen Stool Test detects H. pylori proteins in stool to diagnose active infection. H. pylori is a common cause of gastritis, ulcers, and increased stomach cancer risk. Doctors order this test for patients with abdominal pain, nausea, bloating, or indigestion. Noninvasive and accurate, results confirm active infection and are also used to monitor treatment effectiveness and eradication of H. pylori bacteria.

The 1,5-Anhydroglucitol Intermediate Glycemic Control Test measures short- to mid-term blood sugar stability, offering an advanced indicator of daily glucose control and metabolic health. It bridges the gap between fasting glucose and HbA1c results, helping identify hidden glucose spikes that affect insulin function, diabetes management, and long-term health outcomes.

A comprehensive cardiovascular baseline panel evaluating ApoB, Lipoprotein (a), hs-CRP, Hemoglobin A1c, lipid profile, metabolic markers, and urinary albumin. Designed to assess vascular aging, arterial health, inflammation, metabolic function, and early kidney stress, this panel supports proactive cardiovascular risk evaluation and long-term heart health monitoring.

Comprehensive panel evaluating cardiac strain, myocardial injury, kidney function, metabolic balance, and glycemic control. Measures NT-proBNP, high-sensitivity Troponin T, A1c, CMP, CBC, and urinary albumin to assess the systemic impact of vascular aging and cardiometabolic stress. Designed for structured end-organ surveillance and proactive cardiovascular health monitoring.